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We present a new model for E. coil tyroslne aminotransferase based on the X-ray structures ofthe wild type and Val~gLeu mutant of E. coli aspartate 
aminotransferase ndcorr~puter simulation studies. Active site characteristics of the model are correlated with experimental observations on the 
specificity of these nzymes towards aromatie/dicarboxylic acidsubstmtes. 
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I. INTRODUCTION 
Aspartate aminotransferase (AspAT) is one of the 
most thoroughly studied vitamin B6-dependent enzymes 
[1,2]. It catalyzes the reaction: 
L-aspartate + 2-oxoglutarate ,-, oxaloacetate + 
L-glutamate 
This transamination reaction is a two-step rocess in 
which in step I an L-amino acid and water react with the 
pyridoxal-5'-phosphate (PLP).enzyme to foma a keto 
acid and the pyridoxamine-5'-phosphate(PMP)-en. 
zyme. In step 2, a second keto acid reacts with the PMP 
enzyme to give the corresponding L-amino acid and 
water. In the last decade, several aspartate aminotrans- 
ferases have been successfully crystallized and subjected 
to X-ray crystallographic studies. These investigations 
together with a variety of experimental spectroscopic 
and biochemical data served as a basis for a detailed 
structurally based mechanistic proposal [3,4]. 
The primary structures of a large number of ami- 
notransferases have been determined and compiled [5]. 
Based on criteria such as substrate specificity, subunit 
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molecular weights and quaternary structures, over 50 
distinct enzymes of this family have been identified from 
eukaryotie and prokaryotie sources. The E. coli tyrB 
gene that encodes another member of the transaminase 
family, tyrosine aminotransferase (eTyrAT), has been 
cloned [6] and the protein has been overexpressed. The 
enzyme was characterized biochemically and was stud- 
ied by site-directed mutagenesis to probe structure- 
function relationships [7]. eTyrAT efficiently catalyzes 
the conversion ot only of tyrosine and other aromatic 
but also of the dicarboxylate substrates. How both di- 
earboxylic and aromatic substrates are able to bind to 
the active site of eTyrAT in a productive way is still not 
well understood. Unfortunately, crystallization experi- 
ments in this laboratory with eTyrAT have not been 
successful to date, precluding crystallographic analyses. 
It is evident from primary structure comparisons of 
eAspAT and eTyrAT that these enzymes, which have 
a sequence identity of 42.9% (similarity including con- 
servative xchange,s: 63%) share catalytically and struc- 
turally important residues. The active site region dis- 
plays a sequence identity of approxim,-..tely 85%. Using 
the backbone fold of chicken mitoehondrial AspAT in 
the closed conformation [4], Seville et al. [8] showed that 
a stereoehemically plausible model of eTyrAT can be 
built, requiring only minor changes in the positions of 
the main-chain atoms of mAspAT. The study proposed 
a number of residues as possible determinants of speci- 
ficity for aromatic substrates. Based on this proposal, 
several point mutants of eAspAT have been constructed 
[7,9] in which active site residues found in eTyrAT have 
been introduced ('hybrid active site' mutants). The mu- 
tants have been characterized bioehemieally and the 
spatial structures of the wild type and mutaiat V39L 
eAspAT have been determined [10-12]. In this work we 
present a new model for eTyrAT based on the results 
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of the X-ray structure determination f an eAspAT ac- 
tive site mutant with Val ~9 replaced by Leu and on 
computer simulation experiments. It is expected that 
such a model would be closer to the true structure than 
the previous one [8], since the bacterial enzyme TyrAT 
is more closely related to the previously unknown struc- 
ture of eAspAT than to chicken mAspAT. Further- 
more, recent advances in computational methods were 
used to improve the modelling procedure. The revised 
eTyrAT structure presented herein should be useful for 
analyzing the determinants of enzyme specificity to- 
wards aromatic or dicarboxylic acid substrates. 
2. MATERIALS AND METHODS 
2,1, Crystal structure determination 
Crystals of the V39L mutant of E, coli AspAT were grown in the 
presence of the competitive inhibitor maleatg at pH 7,5 by the hanging 
drop method in space group P2~ [10], Data to 2.5 A resolution were 
collected with a FAST (Enraf-Nonius, Delft, Holland) area detector, 
The structure was solved by molecular eplacement, taking initial 
phases from the model of Seville et al. [8], and refined to a final 
crystallographic R-factor 0.20 using XPLOR [13], Maleate ~vas bound 
in the active site as a Micbaelis-type inhibitor. Further details are 
described elsewhere ([11] and J. Pager et al,, unpublished). 
2,2, Sequence alignments and secondary structure prediction 
Pairwise alignments of the eTyrAT amino acid sequence to a group 
of AspAT sequences, comprising chicken mAspAT, chicken gAspAT 
and eAspAT, were performed using the program BESTFIT [14]. Op. 
timal alignments between two sequences were found by inserting saps 
to maximize the number of matches using the local homology algo- 
rithm of Smith and Waterman [15], Prediction of secondary structural 
elements was also carried out in an effort to obtain additional re- 
straints for the molecular dynamics calculations ( ee below) using both 
the method of Chou and Fasman [16] and a slightly modified method 
of Robson.Gamier [17]. 
2.3, Model building and computer simulation 
The refined coordinates of the V39L:maleate complex (see above) 
served as initial template for the modelHng of eTyrAT. All eAspAT 
side chains that differ from the eTyrAT amino acid seque,3,ce were 
exchanged while maintaining the backbone torsion angles, fne struc- 
ture includes a tyrosine residue modelled as a Miehaelis complex into 
the substrata binding site. The substrata ~t-amino group and the ¢~- 
carboxylate group have been modelled in accordance with various 
9 maleate and .-methylaspartate complex crystal structures of eAspAT 
refined at resolutions between 2,3 A and 2.8 A [10,12], The~e ligands 
form stable complexes mimicking the Michaelis complex with sub- 
strafe and the external aldimine reaction intermediate, respectively. 
The preliminary model was subjected to 300 steps of energy minimiza- 
tion using th¢ XPLOR empirical force field [13], A harmonic potential 
of 50 keal/mol was used to restrain the C= atoms of the model to their 
initial positions. Using the program GROMOS [18] a molecular dy- 
namics (MD) simulation at 600K was run for 50 ps to sample the 
conformational space around the energy minimized structure. The 
structure was subsequently' averaged over the last 30 ps and minimized 
again. Due to the large size of the system the simulations were carried 
out in vacuo with a screened Coalombic potential form ofnonbondlng 
interactions description [19] as implemented in the program 
GROMOS. This approach as been shown to yield trajectories, aver- 
aged structures, and hydrogen bonding patterns that compare favour- 
ably with those calculated for protein systems with explicitly included 
water, while ~ving substantial amounts of computer time. in order 
to utilize the putative secondary structure similarity between eAspAT 
and eTyrAT, the backbone atoms that were predicted to be part of 
secondary structural elements in tile eTyrAT model structure quiva- 
lent to those in the experimental eAspAT structure were also re- 
strained with a harmonic potential of 50 keal/moi. 
3. RESULTS AND DISCUSSION 
3.1. Overall structure attd domain organization of  
e TyrA T 
Inspection of the final model showed that the overall 
structure, the domain organization, the topology of the 
large pleated sheet and the locations of all ~-helices 
within the structure remain the same as in the wild type 
and V39L eAspATs (Fig. 1). Superposition fall equiv- 
alent C~ atoms of single eAspAT and eTyrAT subunits 
(residues 5-409) t gave an r.m.s, deviation of 1.29 A. 
Larger displacements are observed mainly in loop re- 
gions at the surface of the new eTyrAT model. Residues 
27-29, 42--45, 64--67, 120-134, 233, 336-355 and 384-- 
396 show displacements exceeding 2.5 A. Residue 65 is 
an insertion, whereas the segment consisting of residues 
120-134 contains deletions with respect o the amino 
acid sequences ofeAspAT and mAspATs. The previous 
eTyrAT model [8] based on the mAspAT crystal struc- 
ture showed remarkable similarity to it (the r.m.s, devi- 
ation for all equivalent C~ atoms is only 0.35 A). It may 
well be that this close agreement is due to the simplified 
model building procedure. The low r.m.s, deviation of 
0.47 A obtained for the comparison between their mod- 
elled eAspAT structure [8] and the crystal structure of 
mitochondrial AspAT indirectly suggests his since this 
r.m.s, deviation is in fact much larger (!.24 A) if the 
relevant experimentally determined structures are com- 
pared. A number of residues from the N-terminal por- 
tion of the small domain (residues 15-46) in the eTyrAT 
model form together with side chains from the neigh- 
bouring subunit an extensive hydrophobie patch 
around the active site entry. This area of hydrophobic 
contact might be responsible for stabilizing the closed 
conformation ofeTyrAT. Kinetic studies [20] and X-ray 
crystallographic analyses of V39L eAspAT and wild 
type eAspAT, provide xperimental evidence to support 
this notion. The loop consisting of residues 27-30 is 
highly flexible in eAspAT as indicated by a temperature 
factor analysis of eAspAT crystal structures and by the 
fact that the electron density within this region is weak. 
Thus, the quite large deviations between the model of  
eTyrAT and the eAspAT crystal structure in this region 
are plausible. 
3.2. Active site 
In the active site, which can be subdivided into a 
cofactor-binding and a substrate-binding region, most 
of the catalytically important residues of AspATs are 
*The usual convention for sequence numbering based on the (longest) 
pig cytosolie AspAT sequence was followed [2] 
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Table I 
Important variant residues" in the active site region of AspATs and 
TyrATs 
Position eTyrAT ratTyrAT gAspAT cAspAT mAspAT 
t 8 Leu Arg Leu Phe Leu 
37 lie lie Ile Val Vat 
39 Leu Asp Val Ala Ala 
69 Lcu _b Ash Glu Glu 
107 Gly Thr Gly Gly Ser 
141 Olu Set Pro Gin Gly 
142 Ash Lea Ash ASh Ash 
257 Set Ala Scr Ser Ala 
293 ~" Arg lie Ala Thr Pro 
297* Set Cys Ash Ash Asn 
"Conserved residues were collated in [5] and are not listed here. 
Deletion [5]. 
conserved in eTyrAT [20]. Amino acid substitutions 
found in the active site regions of related transaminases 
are collated in Table I. The cofactor binding site in 
TyrAT consists of residues mainly from the large do- 
main but also includes Tyr70* (an asterisk signifies a 
residue from the neighbouring subunit). The hydrogen 
bonding network around the coenzyme p2cridine ring 
and the 5"-phosphate moiety in the present eTyrAT 
model is essentially identical to that determined crystal- 
lographically for AspAT's (Fig. 2A). 
The substrate binding pocket (Fig. 2B) is slightly less 
conserved, as expected from the different substrate 
speeificities. The substitutions found in the vicinity of 
arginine 292", the main determinant of the AspAT sub- 
strate specificity, are also listed in Table I. This region 
includes residues 18, 37, 39, 141, 142, 293* and 297*. 
The two residues following Trp ~4°, i.e. Glu TM and 
Asn ~', both form hydrogen bonds with main-chain and 
side-chain atoms of Arg ~9"-* (not shown). This ensures 
that the guanidinium group does not approach the side 
chain of tyrosine too closely. The guanidinium group is 
further anchored by a salt bridge to Asp ~5 (not shown). 
All these interactions allow for one of the hydrogen 
atoms of the Arg '-92. guanidinium group to point to- 
wards the substrate's tc electron system° forming favour- 
able geometry for a farther attractive interaction [21]. 
In the present eTyrAT model the/3-hydroxyl group of 
SOl 297., which is an asparagine inall AspATs known to 
date, is within hydrogen bonding distance (3.2 A) of the 
phenolic hydroxyl group of the tyrosine substrate. The 
serine/~-hydroxyl group thus seems to serve as hydro- 
gen bond partner for the phenolic hydroxyl group of the 
substrate, most likely directly, or perhaps indirectly via 
a water molecule. The point mutation Ser ~gr* to Asn 
presumably would hinder productive binding of aro- 
matic substrates to eTyrAT by reducing the size of the 
substrate binding pocket. Studies of the mutant N297S 
in eAspAT are being planned to investigate the impor- 
tance of this residue in the transamination f aromatic 
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Fig, 1. Superposition or ~-carbon models of eTyrAT and eAspAT, 
Bzflls and sticks: eTyrAT model; thin lines: V39L mutant eAspAT 
crystal structure. Only residues in one subunit of the dimer are 
numbered. 
amino acids. The present study suggests that binding of 
aromatic substrate side chains to TyrAT is achieved 
through a complex interaction pattern unlike that in- 
volving bidentate hydrogen bonds and salt bridges 
found in AspATs for the interactions of the distal car- 
boxylates in dicarboxylate substrates with Arg ~°'-*. 
From the studies of the V39L mutant of eAspAT [7,8] 
which was expected to shift the substrate specificity to- 
wards aromatic substrates it is clear that this residue 
alone is not responsible for changing the enzyme selec- 
tivity. The distribution of charged groups around 
Arg 292. in TyrAT differs substantially from that in 
AspATs. Thus, it would be expected that the negative 
charges of Asp ~s and GIu TM, which are not present in the 
eAspAT, exert repulsive forces on the negatively 
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Fig. 2. Partial active sites of V39L eA~pAT cr2cstal nd cTyrAT model structures. (A) V39L eAspAT structure. Residues 11 ~'~7, Val ta. lie 3~. Lea ~ 
and Ash ~* form a hydrophobic lid above the substrate binding pocket, shielding it from bulk solvent. The van der Waals' contacts between Lea '~ 
and residues Asff a*, Tyr TM and Tyr :~~ strengthen the subunit-subunit interactions and stabilize the closed conformation. The inhlbitor maleate, 
mimlcking the Michaelis complex with aspartate forms double hydrogen bond/ion pair interactions to the guanidinium groups of both Are TM and 
Are '9-'*. Hydrogen bonds arc indicated by dashed line ;. (B) eTyrAT model. The substitution of Ash -'~7 (fully con~rv~xt in AspAT~) by serine gives 
rise to anenlarged binlding pocket in TyrAT and a different blndlng mode for aromatic substrates. Since lie ~7. Are as', Tyr TM, Are "~:* are all 
conserved inthe active sites of eAspAT and eTyrAT (Table l), Set "~7. is likely to be responsible for the reduced Michaelis constanls, i.¢. high affinity 
binding of aromatic substrates as compared to cAspAT. Tl~e catalytic activity ofeTyrAT towards dicarboxylig acid substra|es remains unchanged 
as Are :~'* is still available for tight binding to the distal carboxylate group. 
charged distal carboxylate groups of  substrates like as- 
partate or glutamate and, therefore, such substrates 
might conceivably bind less tightly to this active site. 
Productive binding of  diearboxylic acid substrates to 
eTyrAT would probably also involve dissociation of  the 
salt bridge between Are :92. and Glu TM. The latter would 
have to be rotated out of  the active site towards the 
solvent. However, cytosolic AspATs also have a gluta- 
mate residue in position 141. The charge distribution in 
these enzymes differs from that in the mitochondrial or 
E. co8 enzymes in that valine instead of  aspartate is 
found in position 15 suggesting that in the cytosolic 
AspATs only Glu TM serves as additional charge anchor 
compensating the flexible extended side chain of  
Are ~9-~*. Experimental data on binding o f  dicarboxylic 
acid substrates to various AspAT's and TyrAT 's  [8,9] 
indicate, however, that both enzymes bind these sub- 
strates approximately equally well. Thus, it would ap- 
pear that either the substrate specificity is not sensitive 
to changes in the local electrostatic environment intro- 
duced by the mutations in position 15 and 141, or that 
the proposed TyrAT structure is not adequate. Prelimi- 
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nary results o f  further work  which is being carr ied out 
in this laboratory  using an electrostatic potential  ap-  
proach and based on the exper imental  and model  struc- 
tures discussed in this paper  substant iate the first not ion 
and further support  the proposed TyrAT  model  struc- 
ture. 
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